New Article Shows Promise of a Psychedelic Without the Hallucinations

[Farooqji]

The research comes amid a widespread rising interest in the use of psychedelics to treat depression and other mental disorders, and suggests possible benefits in neurodegenerative disorders including Parkinson’s.

Ariadne is a psychedelic drug that was studied by the pharmaceutical company Bristol-Myers, but research on the drug was abandoned in the 1970s. In early unpublished trials, the drug was reported to have had wide-ranging effects. These include remission of symptoms in people with schizophrenia and people with Parkinson’s disease and improved cognition in older subjects, the paper’s authors (who include Columbia Chemistry Professor Dalibor Sames) write

news.columbia.edu/news/new-...